CITE-seq: The future of single-cell RNA sequencing analysis

CITE-seq: The future of single-cell RNA sequencing analysis

Kriti Karn
January 15, 2021

Recent advances in next-generation sequencing technologies have made it possible to investigate cellular systems at the level of individual cells. Single-cell RNA sequencing (scRNA-seq) is now widely employed to study cellular heterogeneity and dynamics. It has helped uncover rare cell populations and regulatory relationships between genes and track the trajectories of distinct cell lineages during development. scRNA-seq comes with its own advantages and disadvantages. The islands in the sc-RNA sequencing method are identified by visualizing overlapping transcription profiles of a few distinguishable marker genes which makes it possible to quantify the RNA in a large number of cells in a short time. The main disadvantage is that this technique does not provide any phenotypic information.

The story of an individual cell extends to much more than its RNA. Proteins form the actual workforce of the cell and are involved in a myriad of cellular processes. Messenger RNA (mRNA) transcripts are often considered mimics of proteins, though we know the relative abundance of proteins and mRNA is not one-to-one. Over the past decade, researchers have used flow cytometry to detect protein markers expressed on single cells and classify the cell islands based on the tagged protein expression patterns. The limitation of flow cytometry is that it uses fluorescently-labeled antibodies that can only bind to and assess the levels of cell surface proteins, thus not providing any information on intracellular proteins.

Principles of CITE-Seq

Cellular Indexing of Transcriptomes and Epitopes (CITE-seq)is a new technique devised by scientists at the NY Genome Centre and the Satija lab, that captures a snapshot of both the transcriptome and the cell surface proteins of single cells. It combines highly multiplexed antibody-based detection of protein markers with unbiased transcriptome profiling, for thousands of single cells in parallel.

CITE-seq utilizes antibodies conjugated to oligonucleotides with DNA barcodes. This:

  • helps in the creation of oligo dT-based RNA sequencing libraries
  • enables barcode-based antibody identification
  • allows specific PCR amplification

The identity and abundance of proteins are reflected by the number of reads corresponding to each conjugated DNA barcode. Downstream bioinformatics analysis then provides multimodal information on the state of the cells. Some tools available for CITE-seq single-cell analysis are the CITE-seq Python package and Cellranger. Seurat has also made available a multimodal data analysis pipeline for this application.

Fig 1. Overview of the TotalSeq™ Workflow

Advantages of CITE-seq

  1. The cellular contents are barcoded in single cells, which allows scientists to obtain multiple readouts. Therefore, the characterization of cellular phenotypes in detail is easier than by performing transcriptome sequencing alone.
  2. Previously, protein detection by flow or mass cytometry required optimized panels of antibodies. CITE-seq provides no upper limit to the number of antibodies that can be used to identify cell surface proteins.
  3. Parallelly quantifying both the transcriptome and cell surface proteins of thousand cells reduces the overall cost and time of high-throughput sequencing.

CITE-seq, thus, adds a new dimension to scRNA-seq by combining transcriptomics with immunophenotyping.


  1. Nguyen QH, Pervolarakis N, Nee K, and Kessenbrock K (2018) Experimental Considerations for Single-Cell RNA Sequencing Approaches. Front. Cell Dev. Biol. 6:108. doi: 10.3389/fcell.2018.00108
  2. Oetjen, K. A., Lindblad, K. E., Goswami, M., Gui, G., Dagur, P. K., Lai, C., Dillon, L. W., McCoy, J. P., & Hourigan, C. S. (2018). Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry. JCI insight3(23), e124928.

Subscribe to our Newsletter

Get the latest insights on Biomolecular data and ML

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Blog Categories